Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE9070.80116.3 (+1.3 %)
PREV CLOSE () 8954.50
OPEN PRICE () 8999.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1176
TODAY'S LOW / HIGH ()8974.05 9219.25
52 WK LOW / HIGH ()6501.6 10653.05
NSE9068.00107.5 (+1.2 %)
PREV CLOSE() 8960.50
OPEN PRICE () 8970.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 9068.00 (8)
VOLUME 24185
TODAY'S LOW / HIGH() 8970.50 9220.00
52 WK LOW / HIGH ()6620.1 10691
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1979

Management Info :

Shilpa Divekar Nirula - Chairman - Managing Director

Registered Office :

Address : Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone : 080 6774 8000

Registrar's Details : Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore
Listing : BSE, NSE
NEWS
10Feb AstraZeneca Pharma gets CDSCO nod to i
AstraZeneca Pharma India has received permission from the Central Drugs..
10Feb AstraZeneca Pharma India informs about
AstraZeneca Pharma India has informed that it has received permission fr..
31Jan AstraZeneca Pharma gets nod to import
AstraZeneca Pharma India has received permission from the Central Drugs..
18Dec AstraZeneca Pharma gets permission for
AstraZeneca Pharma India has received permission from the Central Drugs..
18Dec AstraZeneca Pharma rises on getting pe
Astrazeneca Pharma India is currently trading at Rs. 9090.00, up by 64.2..
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit325.91157.4
Gross Profit 465.4 1563.6
Operating Profit 499.62946
Net Sales 6115.717162.9
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Divi's Lab (BSE)
 6474.50 (4.89%)
M.Cap ( in Cr)
171877.63
Pfizer (BSE)
 5201.35 (4.76%)
M.Cap ( in Cr)
23795.00
Fredun Pharma (BSE)
 1882.50 (5.59%)
M.Cap ( in Cr)
1010.15
Glaxosmithkline Phar (BSE)
 2700.80 (3.09%)
M.Cap ( in Cr)
45753.18
Alkem Laboratories (BSE)
 5887.85 (1.28%)
M.Cap ( in Cr)
70398.08
Shareholding Pattern
PROMOTERS 75%
NON-INSTITUTION 16.74%
MUTUAL FUNDS/UTI 5.43%
FI/BANKS/INSURANCE 0.05%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX84233.64-40.28 (-0.05%)
NIFTY25953.8518.70 (0.07%)
Dow Jones 50188.1452.27 (0.10%)
Nasdaq 23102.47-136.20 (-0.59%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI